Comparative pharmacokinetics of two florfenicol formulations following intramuscular and subcutaneous administration to sheep
Search for other papers by Christie C. Balcomb in
Current site
Google Scholar
PubMed
Search for other papers by John A. Angelos in
Current site
Google Scholar
PubMed
Search for other papers by Munashe Chigerwe in
Current site
Google Scholar
PubMed
Search for other papers by Barbara A. Byrne in
Current site
Google Scholar
PubMed
Search for other papers by V. Michael Lane in
Current site
Google Scholar
PubMed
Search for other papers by Scott E. Wetzlich in
Current site
Google Scholar
PubMed
Search for other papers by Orhan Sahin in
Current site
Google Scholar
PubMed
Search for other papers by Larry Holler in
Current site
Google Scholar
PubMed
Search for other papers by Shuping Zhang in
Current site
Google Scholar
PubMed
Search for other papers by Lisa A. Tell in
Current site
Google Scholar
PubMed
Abstract
OBJECTIVE To compare the pharmacokinetics of 2 commercial florfenicol formulations following IM and SC administration to sheep.
ANIMALS 16 healthy adult mixed-breed sheep.
PROCEDURES In a crossover study, sheep were randomly assigned to receive florfenicol formulation A or B at a single dose of 20 mg/kg, IM, or 40 mg/kg, SC. After a 2-week washout period, each sheep was administered the opposite formulation at the same dose and administration route as the initial formulation. Blood samples were collected immediately before and at predetermined times for 24 hours after each florfenicol administration. Plasma florfenicol concentrations were determined by high-performance liquid chromatography. Pharmacokinetic parameters were estimated by noncompartmental methods and compared between the 2 formulations at each dose and route of administration.
RESULTS Median maximum plasma concentration, elimination half-life, and area under the concentration-time curve from time 0 to the last quantifiable measurement for florfenicol were 3.76 μg/mL, 13.44 hours, and 24.88 μg•h/mL, respectively, for formulation A and 7.72 μg/mL, 5.98 hours, and 41.53 μg•h/mL, respectively, for formulation B following administration of 20 mg of florfenicol/kg, IM, and 2.63 μg/mL, 12.48 hours, and 31.63 μg•h/mL, respectively, for formulation A and 4.70 μg/mL, 16.60 hours, and 48.32 μg•h/mL, respectively, for formulation B following administration of 40 mg of florfenicol/kg, SC.
CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that both formulations achieved plasma florfenicol concentrations expected to be therapeutic for respiratory tract disease caused by Mannheimia haemolytica or Pasteurella spp at both doses and administration routes evaluated.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 150 | 0 | 0 |
| Full Text Views | 1773 | 1092 | 151 |
| PDF Downloads | 798 | 350 | 18 |
- PubMed Citation
- Article by Christie C. Balcomb
- Article by John A. Angelos
- Article by Munashe Chigerwe
- Article by Barbara A. Byrne
- Article by V. Michael Lane
- Article by Scott E. Wetzlich
- Article by Orhan Sahin
- Article by Larry Holler
- Article by Shuping Zhang
- Article by Lisa A. Tell
- Similar articles in PubMed
